Rice Hall James & Associates, LLC Emergent Bio Solutions Inc. Transaction History

Rice Hall James & Associates, LLC

$1.66 Billion
Q4 2024

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 01, 2022	SELL	$20.09 - $35.8 $4.18 Million - $7.45 Million	-208,137 Reduced 79.58%	53,396 $1.12 Million
Q2 2022 Aug 08, 2022	SELL	$27.42 - $43.63 $1.13 Million - $1.8 Million	-41,188 Reduced 13.61%	261,533 $8.12 Million
Q1 2022 May 05, 2022	SELL	$36.48 - $52.22 $1.48 Million - $2.12 Million	-40,626 Reduced 11.83%	302,721 $12.4 Million
Q4 2021 Feb 14, 2022	SELL	$33.11 - $55.01 $944,992 - $1.57 Million	-28,541 Reduced 7.67%	343,347 $14.9 Million
Q3 2021 Nov 09, 2021	SELL	$50.07 - $66.05 $1.78 Million - $2.34 Million	-35,459 Reduced 8.7%	371,888 $18.6 Million
Q2 2021 Jul 29, 2021	SELL	$56.61 - $80.46 $5.52 Million - $7.85 Million	-97,511 Reduced 19.31%	407,347 $25.7 Million
Q1 2021 May 14, 2021	SELL	$86.23 - $125.19 $7.15 Million - $10.4 Million	-82,869 Reduced 14.1%	504,858 $46.9 Million
Q4 2020 Feb 16, 2021	SELL	$79.17 - $111.47 $2.8 Million - $3.95 Million	-35,405 Reduced 5.68%	587,727 $52.7 Million
Q3 2020 Nov 16, 2020	SELL	$81.91 - $134.94 $3.21 Million - $5.29 Million	-39,217 Reduced 5.92%	623,132 $64.4 Million
Q2 2020 Aug 14, 2020	SELL	$54.33 - $89.52 $5.59 Million - $9.21 Million	-102,853 Reduced 13.44%	662,349 $52.4 Million
Q1 2020 May 15, 2020	SELL	$49.34 - $68.76 $16.6 Million - $23.1 Million	-335,563 Reduced 30.48%	765,202 $44.3 Million
Q4 2019 Jan 29, 2020	SELL	$51.21 - $59.06 $6.56 Million - $7.56 Million	-128,026 Reduced 10.42%	1,100,765 $59.4 Million
Q3 2019 Oct 30, 2019	BUY	$40.6 - $57.2 $1.02 Million - $1.44 Million	25,125 Added 2.09%	1,228,791 $64.2 Million
Q2 2019 Aug 01, 2019	SELL	$39.92 - $53.86 $670,176 - $904,201	-16,788 Reduced 1.38%	1,203,666 $58.1 Million
Q1 2019 May 01, 2019	SELL	$48.23 - $66.16 $6.53 Million - $8.96 Million	-135,495 Reduced 9.99%	1,220,454 $61.7 Million
Q4 2018 Feb 14, 2019	BUY	$55.63 - $73.24 $13.4 Million - $17.6 Million	240,074 Added 21.51%	1,355,949 $80.4 Million
Q3 2018 Oct 25, 2018	SELL	$52.05 - $66.51 $1.31 Million - $1.67 Million	-25,146 Reduced 2.2%	1,115,875 $73.5 Million
Q2 2018 Aug 02, 2018	BUY	$48.33 - $55.64 $8.44 Million - $9.72 Million	174,614 Added 18.07%	1,141,021 $57.6 Million
Q1 2018 Apr 25, 2018	BUY	$44.44 - $54.39 $8.77 Million - $10.7 Million	197,311 Added 25.65%	966,407 $50.9 Million
Q4 2017 Jan 23, 2018	BUY	$37.77 - $47.75 $4.76 Million - $6.02 Million	126,069 Added 19.61%	769,096 $35.7 Million
Q3 2017 Oct 30, 2017	BUY	$34.14 - $40.45 $22 Million - $26 Million	643,027	643,027 $26 Million

Others Institutions Holding EBS

# of Institutions

172

Shares Held

36.8M

Call Options Held

336K

Put Options Held

203K

View Full List

About Emergent BioSolutions Inc.

Ticker EBS
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,861,500
Market Cap $384M
Description
Emergent BioSolutions Inc., a life sciences company, focuses on the provision of preparedness and response solutions that address accidental, deliberate, and naturally occurring public health threats (PHTs) in the United States. The company's products address PHTs, which include chemical, biological, radiological, nuclear, and explosives; emergi...

More about EBS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Rice Hall James & Associates, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Rice Hall James & Associates, LLC with notifications on news.

Account